Haemophilia
Recommendations related to haemophilia
Tag overview
recommendation across 1 inquiry
Across 1 inquiry
Tagged Recommendations
Haemophilia Peer Review
That peer review of haemophilia care should continue to occur as presently practised, with any necessary support being provided by NHS Trusts and Health Boards;
Trust/Board Action on Peer Reviews
That NHS Trusts and Health Boards should be required to deliberate on peer review findings and give favourable consideration to implementing the changes identified with a view to ensuring comprehensive, …
Five-Year Peer Review Cycle
A peer review of each centre should take place not less than once every five years.
Haemophilia Centre Resources
The necessary administrative and clinical resources should be provided by hospital trusts and boards, integrated care boards, and service commissioners to facilitate multi-disciplinary regional networks to discuss policy and practice …
Recombinant Products Over Plasma-Derived
Recombinant coagulation factor products should be offered in place of plasma-derived ones where clinically appropriate. Service commissioners should ensure that such treatment decisions are funded accordingly.
National Haemophilia Database Support
That the National Haemophilia Database, run by the UKHCDO, merits the support of additional central funding.